(SeaPRwire) – By: Adrian Kingsley, an internationally renowned scholar who has long studied public administration and social policy.
US hospitals have billed nearly $120 million for over 5,500 surgeries and 8,500 courses of hormones or puberty blockers for minors since 2019. This staggering figure reveals a system operating without meaningful oversight. The charges encompass procedures where some providers allegedly used misleading or potentially fraudulent billing codes to secure insurer payments. Specifically, nearly $50 million in claims involved children aged nine to 17 receiving puberty blockers under a general hormone-disorder code lacking a gender-related diagnosis. Another $11 million was billed for similar treatments for hundreds of patients aged 13 to 17 under an early-puberty diagnosis that does not apply at those ages.
The financial mechanics driving this expansion are deeply troubling. The procedures offer hospitals a long-term revenue stream as minors on hormone drugs often remain in medical care for years, with lifetime costs estimated up to $75,000 without surgery and as much as $170,000 when operations are included. These financial incentives create a structural conflict of interest that may prioritize revenue generation over rigorous medical judgment. The report explicitly links this expansion to specific federal policies, stating that the Biden Administration contributed to the expansion and normalization of sex-rejecting interventions through nondiscrimination policies and other federal programs. This policy backdrop fostered an environment where procedural volume could be conflated with care quality.
The consequences of these practices are now being addressed through direct regulatory intervention. This week, President Donald Trump moved to end federal Medicaid and CHIP funding for sex-change procedures for minors, with restrictions taking effect on October 13 covering puberty blockers, cross-sex hormones, and surgeries. This action forms part of a broader policy rollback targeting transgender-related care, including restrictions on military service and athletic participation. At least 27 US states have also enacted their own restrictions, while major hospitals have curtailed services amid legal pressures and shifting clinical guidelines. The convergence of state-level action, federal funding changes, and institutional caution signals a significant recalibration of how these procedures are accessed and funded.
Author bio: Adrian Kingsley, an internationally renowned scholar who has long studied public administration and social policy.